Antonio Abbate, M.D., Ph.D., associate professor in the School of Medicine, is one of several winners of funding from the first round of the The Quest Commercialization Fund.

Second round of Quest Commercialization Fund applications open until March 30

Share this story

The Quest Commercialization Fund is now accepting applications for its second round of proof-of-concept funding.

Administered through the Innovation Gateway, the Quest Commercialization Fund is dedicated to advancing VCU inventions to a more mature stage and improving their chances of being brought to market.

On March 1, the Fund began accepting applications from any Virginia Commonwealth University faculty, staff, trainees and students who have inventions and projects in need of a financial boost to get to market. Applications will close at noon on Thursday, March 30.

In this second round of funding, a total of $150,000 is available, with a maximum of $50,000 per project. The Proof-of-Concept Review Board will assess applications and present recommendations to the Office of the President. Funds will be awarded in May. 

List of winners of funding from the first round: 

  • Youngman Oh, Ph.D., professor of pathology, biochemistry and molecular biology, for development of a novel targeted antibody therapy for triple-negative breast cancer
  • Antonio Abbate, M.D., Ph.D., associate professor, and Stefano Toldo, Ph.D., assistant professor, both in the School of Medicine, for treatment of myocardial infarction 
  • Hong Zhao, Ph.D., assistant professor in the School of Engineering for a dual-channel jetting apparatus for 2-D/3-D electro hydrodynamic printing 
  • William Paul Murphy, M.D., assistant professor, anesthesiology in the School of Medicine for novel anesthesia equipment that allows airway equipment to remain clean and available for use while protecting the patient and the environment from contamination. 
  • Jayasimha Atulasimha, Ph.D., associate professor in the School of Engineering for energy-efficient memory devices based on skyrmions 
  • David Saul, Illya Kajan, Matthew Leccadito, Boris Solomonov, Alex Ucci, all from the da Vinci Center, for an electronic alcohol tester 

 

Visit http://quest.vcu.edu/innovation/commercialization/ for additional information.